Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1280620rdf:typepubmed:Citationlld:pubmed
pubmed-article:1280620lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1280620lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:1280620lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:1280620lifeskim:mentionsumls-concept:C0056184lld:lifeskim
pubmed-article:1280620lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:1280620pubmed:issue2-4lld:pubmed
pubmed-article:1280620pubmed:dateCreated1993-1-7lld:pubmed
pubmed-article:1280620pubmed:abstractTextA soluble form of complement receptor number 2 (sCR2) found in human serum closely resembles that produced in culture by B lymphoblastoid cells. Epitope analysis with a panel of CD21 monoclonal antibodies revealed only minor differences between antigen from the two sources. Purified sCR2 from both sources bound to C3dg prepared from human or mouse serum and to u.v.-inactivated Epstein-Barr virus. SDS-PAGE analysis of culture supernates of B-lymphoid cells labelled by growth in medium containing 35S-methionine revealed a major component of molecular weight approximately 130 kDa and another band at 30 kDa. Incubation with endoglycosidase F reduced the size of the high molecular weight component. Gel filtration of untreated serum or culture supernate revealed that, in its native state, sCR2 behaved as a molecule or complex of apparent molecular weight 320 kDa. Possible explanations are discussed.lld:pubmed
pubmed-article:1280620pubmed:languageenglld:pubmed
pubmed-article:1280620pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1280620pubmed:citationSubsetIMlld:pubmed
pubmed-article:1280620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1280620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1280620pubmed:statusMEDLINElld:pubmed
pubmed-article:1280620pubmed:monthAuglld:pubmed
pubmed-article:1280620pubmed:issn0171-2985lld:pubmed
pubmed-article:1280620pubmed:authorpubmed-author:BrownBBlld:pubmed
pubmed-article:1280620pubmed:authorpubmed-author:LingN RNRlld:pubmed
pubmed-article:1280620pubmed:issnTypePrintlld:pubmed
pubmed-article:1280620pubmed:volume185lld:pubmed
pubmed-article:1280620pubmed:ownerNLMlld:pubmed
pubmed-article:1280620pubmed:authorsCompleteYlld:pubmed
pubmed-article:1280620pubmed:pagination403-14lld:pubmed
pubmed-article:1280620pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:meshHeadingpubmed-meshheading:1280620-...lld:pubmed
pubmed-article:1280620pubmed:year1992lld:pubmed
pubmed-article:1280620pubmed:articleTitleProperties of soluble CR2 in human serum.lld:pubmed
pubmed-article:1280620pubmed:affiliationDepartment of Immunology, Medical School, Birmingham, U.K.lld:pubmed
pubmed-article:1280620pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1280620pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1280620lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1280620lld:pubmed